Amferia kills bacteria

medical devices

About

Amferia is a Swedish medtech company founded in 2016 by three PhD researchers from Chalmers University of Technology. The company focuses on developing antimicrobial healthcare solutions using a proprietary amphiphilic hydrogel technology. This innovative hydrogel binds and kills various types of bacteria, including antibiotic-resistant strains, while being safe for surrounding tissue. Amferia's product line includes antimicrobial wound dressings designed for both human and animal health. The company has established a commercial partnership with Orkla Wound Care to introduce a wound dressing for animals that effectively targets resistant bacteria. With a strong patent portfolio in Europe, the U.S., and China, Amferia is committed to advancing its technology and expanding into various medical device markets. The company's mission is to address the global health threat of antibiotic-resistant infections by providing safer and more effective infection control solutions.

Technologies

Outlook Microsoft Office 365 Amazon AWS Ruby On Rails YouTube Cision Google Tag Manager Varnish Mobile Friendly reCAPTCHA Circle

Keywords

antibacterial materials antibiotic resistance elastomers injectable materials medical equipment manufacturing product development wound infection prevention medical applications antimicrobial spray pharmaceuticals veterinary wound care antimicrobial peptides antimicrobial biofilm prevention antimicrobial hydrogel infection control scientific research amphiphilic hydrogel drug delivery systems veterinary medicine medical equipment and supplies manufacturing b2b bioinspired antimicrobial material implant coatings hydrogel wound dressing resistant bacteria peer-reviewed studies bioinspired polymers drug-resistant bacteria regulatory approval safety and efficacy

Location

1 Pepparedsleden, Moelndal, Vaestra Goetaland County, Sweden, 431 53

Related Companies

Companies in the same industry